Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23956 AL 23970

Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jun;21(6):e14333. doi: 10.1002/alz.14333. Epub 2024 Dec 23.

Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial

Grill JD, Raman R, Flournoy C, Ernstrom K, Pierce A, Smith A, Rosenberg P, Burns J, Karlawish J, Aisen P, Holdridge KC, Mancini M, Sperling R, Sultzer D; A4 Study Team.

Alzheimers Dement. 2025 Feb;21(2):e14623. doi: 10.1002/alz.14623.

Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand

Taweephol T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, Luechaipanit W, Haethaisong T, Chongsuksantikul A, Likitjaroen Y, Thanapornsangsuth P.

J Alzheimers Dis. 2025 Mar;104(2):325-330. doi: 10.1177/13872877251316546. Epub 2025 Feb 9.

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid]

Ono N, Maruyama G, Akaiwa Y, Nakamura T, Tamai C, Sone J, Miyamoto T.

Rinsho Shinkeigaku. 2025 Dec 19;65(12):912-915. doi: 10.5692/clinicalneurol.cn-002153. Epub 2025 Nov 22.

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases

Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F.

Acta Neurol Belg. 2025 Jun;125(3):691-698. doi: 10.1007/s13760-025-02759-2. Epub 2025 Mar 11.

Zinc transporter proteins in the retina as potential biomarkers for staging early Alzheimer's disease: Comparative analysis in human and mouse models

Mashkani SMH, Bishop D, Adlard PA, Mojtaba Golzan S.

Neurobiol Aging. 2026 Jan;157:26-35. doi: 10.1016/j.neurobiolaging.2025.09.010. Epub 2025 Oct 1.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

Hong YJ, Choi SH, Kim S, Jeong JH, Park KH, Wang MJ, Kang S, Yang DW; CoSCo study group.

Alzheimers Dement. 2025 Feb;21(2):e14473. doi: 10.1002/alz.14473. Epub 2024 Dec 28.

Comparison of Methods of Detecting IL-1β in the Blood of Alzheimer's Disease Subjects

Remnitz AD, Hadad R, Keane RW, Dietrich WD, de Rivero Vaccari JP.

Int J Mol Sci. 2025 Jan 20;26(2):831. doi: 10.3390/ijms26020831.

Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis

Webster H, Zelinsky M, Rico V, Martinez K, Sankary L.

J Alzheimers Dis. 2026 Mar;110(1):46-57. doi: 10.1177/13872877251392555. Epub 2025 Nov 5.

[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]

Hansen N, Wiltfang J.

Fortschr Neurol Psychiatr. 2025 Nov;93(11):446-452. doi: 10.1055/a-2698-5992. Epub 2025 Nov 6.

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison

Botella M, Estanga A, Ros N, Saldias J, Cañada M, García-Sebastián M, Larrea JÁ, Echeverria M, Garrido A, Altuna M.

J Alzheimers Dis. 2026 Feb;109(3):1508-1519. doi: 10.1177/13872877251407121. Epub 2025 Dec 30.

Identifying sex- and gender-specific endocrinological, lifestyle, psychosocial, and socio-cultural targets for Alzheimer's disease prevention in Africans: The Female Brain Health and Endocrine Research in Africa (FemBER-Africa) project

Udeh-Momoh CT, Aliwa B, Atwoli L, Blackmon K, Bosire E, Gitau S, Kaleli H, Kamanda C, Khakali L, Maina R, Mativo P, Mbugua S, Merali Z, Muchungi K, Njogu N, Nyankira D, Okech V, Ondieki A, Onyancha C, Onyango SO, Shah J, Shah S, Smith C, Sokhi D, Waa S, Gregory S, Hill-Jarrett TG, Kafetsouli D, Mielke MM, Muniz-Terrera G, Solomon A, Thesen T, Tsoy E, Yasoda-Mohan A, Yokoyama JS, Watermeyer TJ.

Alzheimers Dement. 2025 Nov;21(11):e70887. doi: 10.1002/alz.70887.

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies

Aveneau C, Lamy E, Grassin-Delyle S, Sanchez-Ortiz M, Vicaut E, Touchard C, Cognat E, Dumurgier J, Hourregue C, Hugon J, Bouaziz-Amar E, Paquet C.

J Alzheimers Dis. 2025 Dec;108(3):1339-1346. doi: 10.1177/13872877251387159. Epub 2025 Oct 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias